EX-23.1
Published on March 27, 2017
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption Experts and to the use of our reports dated February 23, 2017, included in the Proxy Statement/Prospectus/Information Statement of OncoGenex Pharmaceuticals, Inc. that is made a part of the Registration Statement on Form S-4 of OncoGenex Pharmaceuticals, Inc. dated March 27, 2017.
Vancouver, Canada | /s/ Ernst & Young LLP | |||||
March 27, 2017 | Chartered Professional Accountants |